Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jun 8, 2026 · Filed Jun 11, 2026
A major shareholder of Inmed Pharmaceuticals paid $45K out of pocket for Inmed Pharmaceuticals shares. 1 other person at Inmed Pharmaceuticals bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$44,867
Shares × reported transaction price
$25K–$100K
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 16 earlier confirmed purchases
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $7.70 on Jun 8, 2026, 150% above its 52-week low and 60% below its high, after a 100% rise over the previous 30 trading days
52-week range $3.08 (Mar 30, 2026) to $19.35 (Jun 24, 2025), 28% of the way up, from 251 adjusted closes. 30 trading days earlier: $3.86 on Apr 24, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −0.7% | +0.4% | −1.0% |
| 30 days | +4.0% | +1.0% | +3.0% |
| 90 days | −13.3% | +2.2% | −15.4% |
Past results only. Not a forecast.
Insider buying
Traded Jun 30 · filed 3 days later
A major shareholder of Inmed Pharmaceuticals paid $839 out of pocket for Inmed Pharmaceuticals shares. 1 other person at Inmed Pharmaceuticals bought some too, in the same month.
Insider buying
Traded Jun 30 · filed 3 days later
A major shareholder of Inmed Pharmaceuticals paid $85 out of pocket for Inmed Pharmaceuticals shares. 1 other person at Inmed Pharmaceuticals bought some too, in the same month.
Insider buying
Traded Jul 1 · filed 2 days later
A major shareholder of Inmed Pharmaceuticals paid $6.1K out of pocket for Inmed Pharmaceuticals shares. 1 other person at Inmed Pharmaceuticals bought some too, in the same month.
Vivo Opportunity, LLC, 10% owner's past purchases, 90 days after disclosure: 3 buys, median −15.4 pts vs S&P 500, beat it 0 of 3 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
